Hyperphosphatemia and hypocalcemia, resulting from impaired renal activation of vitamin D, trigger increased production of FGF-23 and parathyroid hormone (PTH), leading to renal secondary hyperparathyroidism (RSHP) [18]. Here, PTH is linked to hyperphosphatemia.